FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285589232> ?p ?o ?g. }

• W4285589232 abstract "The efficacy and tolerability of eslicarbazepine acetate (ESL) in adults and children with focal-onset epilepsy (FOE) according to the dose remain to be validated. A meta-analysis based on randomized controlled trials (RCTs) was therefore conducted as a summary.Relevant RCTs were collected by systematic searching the electronic databases of PubMed, Cochrane's Library, Embase, Wanfang and CNKI from inception to May 16, 2022. The random-effect model was adopted to pool the results by incorporating the possible heterogeneity. Efficacy outcomes including responsive rate and effective rate, defined as cases with 50 and ≥75% reduction in seizure frequency compared to baseline, were determined, respectively. Incidence of severe adverse events (AE) leading to drug discontinuation was also evaluated.Ten studies including 2,565 people with epilepsy contributed to the meta-analysis. For adults, ESL 400 mg/d did not improve the response rate or the effective rate; ESL 800 mg/d was associated with improved response rate (odds ratio [OR] 2.16, 95% confidence interval [CI]: 1.65-2.83, p < 0.001) and effective rate (OR 2.16, 95% CI: 1.41-3.30, p < 0.001) without significantly increased severe AE (OR 1.58, 95% CI: 0.90-2.78, p = 0.11); ESL 1,200 mg/d improved response rate (OR 2.49, p < 0.001) and effective rate (OR 3.09, p = 0.04), but significantly increased severe AE (OR 3.72, p < 0.001). For children, ESL also did not significantly improve the response rate (OR 1.76, p = 0.22) or the effective rate (OR 2.17, p = 0.13).ESL 800 mg/d is effective and well-tolerated as adjuvants for adults with FOE. Efficacy of ESL in children with FOE should be further evaluated." @default.
• W4285589232 created "2022-07-16" @default.
• W4285589232 creator A5048341131 @default.
• W4285589232 creator A5055297240 @default.
• W4285589232 creator A5055570035 @default.
• W4285589232 date "2022-07-15" @default.
• W4285589232 modified "2023-09-30" @default.
• W4285589232 title "Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis" @default.
• W4285589232 cites W1572262481 @default.
• W4285589232 cites W1978285852 @default.
• W4285589232 cites W1980087402 @default.
• W4285589232 cites W1984234523 @default.
• W4285589232 cites W1995505488 @default.
• W4285589232 cites W2026487858 @default.
• W4285589232 cites W2040070465 @default.
• W4285589232 cites W2042774009 @default.
• W4285589232 cites W2082045121 @default.
• W4285589232 cites W2115706298 @default.
• W4285589232 cites W2126930838 @default.
• W4285589232 cites W2157823046 @default.
• W4285589232 cites W2399400964 @default.
• W4285589232 cites W2594644573 @default.
• W4285589232 cites W2606788387 @default.
• W4285589232 cites W2766414905 @default.
• W4285589232 cites W2792615733 @default.
• W4285589232 cites W2794104372 @default.
• W4285589232 cites W2898649079 @default.
• W4285589232 cites W2905495894 @default.
• W4285589232 cites W2978795816 @default.
• W4285589232 cites W2995459561 @default.
• W4285589232 cites W3008155934 @default.
• W4285589232 cites W3009448536 @default.
• W4285589232 cites W3012498005 @default.
• W4285589232 cites W3012636246 @default.
• W4285589232 cites W3035511928 @default.
• W4285589232 cites W3087012434 @default.
• W4285589232 cites W3087545506 @default.
• W4285589232 cites W3097589154 @default.
• W4285589232 cites W3118615836 @default.
• W4285589232 cites W3119162699 @default.
• W4285589232 cites W3123893780 @default.
• W4285589232 cites W3124834258 @default.
• W4285589232 cites W3162867094 @default.
• W4285589232 cites W3202652452 @default.
• W4285589232 cites W3212012921 @default.
• W4285589232 cites W4205340155 @default.
• W4285589232 cites W4226355851 @default.
• W4285589232 doi "https://doi.org/10.3389/fneur.2022.909471" @default.
• W4285589232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35911890" @default.
• W4285589232 hasPublicationYear "2022" @default.
• W4285589232 type Work @default.
• W4285589232 citedByCount "0" @default.
• W4285589232 crossrefType "journal-article" @default.
• W4285589232 hasAuthorship W4285589232A5048341131 @default.
• W4285589232 hasAuthorship W4285589232A5055297240 @default.
• W4285589232 hasAuthorship W4285589232A5055570035 @default.
• W4285589232 hasBestOaLocation W42855892321 @default.
• W4285589232 hasConcept C118552586 @default.
• W4285589232 hasConcept C126322002 @default.
• W4285589232 hasConcept C156957248 @default.
• W4285589232 hasConcept C167704817 @default.
• W4285589232 hasConcept C168563851 @default.
• W4285589232 hasConcept C197934379 @default.
• W4285589232 hasConcept C2776478404 @default.
• W4285589232 hasConcept C2778186239 @default.
• W4285589232 hasConcept C2778375690 @default.
• W4285589232 hasConcept C2778715236 @default.
• W4285589232 hasConcept C38652104 @default.
• W4285589232 hasConcept C41008148 @default.
• W4285589232 hasConcept C44249647 @default.
• W4285589232 hasConcept C71924100 @default.
• W4285589232 hasConcept C79736992 @default.
• W4285589232 hasConcept C95190672 @default.
• W4285589232 hasConceptScore W4285589232C118552586 @default.
• W4285589232 hasConceptScore W4285589232C126322002 @default.
• W4285589232 hasConceptScore W4285589232C156957248 @default.
• W4285589232 hasConceptScore W4285589232C167704817 @default.
• W4285589232 hasConceptScore W4285589232C168563851 @default.
• W4285589232 hasConceptScore W4285589232C197934379 @default.
• W4285589232 hasConceptScore W4285589232C2776478404 @default.
• W4285589232 hasConceptScore W4285589232C2778186239 @default.
• W4285589232 hasConceptScore W4285589232C2778375690 @default.
• W4285589232 hasConceptScore W4285589232C2778715236 @default.
• W4285589232 hasConceptScore W4285589232C38652104 @default.
• W4285589232 hasConceptScore W4285589232C41008148 @default.
• W4285589232 hasConceptScore W4285589232C44249647 @default.
• W4285589232 hasConceptScore W4285589232C71924100 @default.
• W4285589232 hasConceptScore W4285589232C79736992 @default.
• W4285589232 hasConceptScore W4285589232C95190672 @default.
• W4285589232 hasLocation W42855892321 @default.
• W4285589232 hasLocation W42855892322 @default.
• W4285589232 hasLocation W42855892323 @default.
• W4285589232 hasLocation W42855892324 @default.
• W4285589232 hasOpenAccess W4285589232 @default.
• W4285589232 hasPrimaryLocation W42855892321 @default.
• W4285589232 hasRelatedWork W2059313976 @default.
• W4285589232 hasRelatedWork W2089245388 @default.
• W4285589232 hasRelatedWork W2286371484 @default.
• W4285589232 hasRelatedWork W2754480517 @default.
• W4285589232 hasRelatedWork W2896659597 @default.

• next